Invention Grant
US08354532B2 Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
有权
吡咯并[2,3-D]嘧啶作为治疗HIV的非核苷逆转录酶抑制剂
![Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV](/docs/US/2013-01-15/US08354532B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
- Patent Title (中): 吡咯并[2,3-D]嘧啶作为治疗HIV的非核苷逆转录酶抑制剂
-
Application No.: US13470116Application Date: 2012-05-11
-
Publication No.: US08354532B2Publication Date: 2013-01-15
- Inventor: Jean-Luc Girardet , Yung-hyo Koh , Stephanie Shaw , Hong Woo Kim , Zhi Hong
- Applicant: Jean-Luc Girardet , Yung-hyo Koh , Stephanie Shaw , Hong Woo Kim , Zhi Hong
- Applicant Address: US CA San Diego
- Assignee: Ardea Biosciences, Inc.
- Current Assignee: Ardea Biosciences, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wilson, Sonsini, Goodrich & Rosati
- Main IPC: C07D487/00
- IPC: C07D487/00
![Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV](/abs-image/US/2013/01/15/US08354532B2/abs.jpg.150x150.jpg)
Abstract:
This application concerns certain 2-phenylamino-6-aryl amino-, 6-aryloxy-, and 6-arylthio-purines, -azapurines and -deazapurines. These compounds are non-nucleoside reverse transcriptase inhibitors and have potential as anti-HIV treatment.
Public/Granted literature
- US20120226037A1 PYRROLO [2,3-D] PYRIMIDINES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF HIV Public/Granted day:2012-09-06
Information query
